Pear Therapeutics Announces Process Exploring Strategic Alternatives
Digital Health Global
MARCH 18, 2023
BOSTON–( BUSINESS WIRE )– Pear Therapeutics, Inc. (Nasdaq: PEAR) (“the Company”), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced that it is engaged in a process to explore strategic alternatives to maximize shareholder value. The Company has engaged MTS Health Partners, L.P. to act as the Company’s exclusive financial advisor to assist in evaluating potential alternatives.
Let's personalize your content